CTnI Troponin I Rapid Test Kit 0.1-50ng/ML Special Protein

CTnI Overview

Creatine i (CTnI) is a special protein in myocardial cells. It has the function of regulating myocardial cell contraction. It is widely applied in the clinical diagnosis of myocardial damage and unstable angina. In these patients, ctni appears earlier and lasts longer. Myocardial specificity, which is the first diagnostic index of myocardial infarction, requires a relatively long diagnosis time.

CTnI performance index

CTnI Clinical significance

• The first choice marker in the diagnosis of myocardial infarction (MI).
• We measured infarct size and stratified risk.
• Prognosis in patients with acute myocardial infarction
• Diagnosis and differential diagnosis of acute dyspnea

Access to diagnosis and risk stratification of ACS (ESC guidelines 2007)

See a doctor	Chest pain / tightness
Medical records and physical examinations	Suspected ACS (Acute Coronary syndrome)
electrocardiogram	Persistent ST segment elevation	Abnormal St/T segment ↓		ECG normal ↓
Biochemical test	↓Confirm	CTN was positive		Troponin CTN negative ×2
Risk stratification		high-risk		Low risk
diagnosis	St-segment elevation myocardial infarction	NSTEMI in non ST segment elevation myocardial infarction		UA of unstable angina pectoris
treatment	Reperfusion	interventional therapy		Non interventional therapy

Application Department

Cardiology, emergency, examination room, pediatrics, hematology, oncology, Nephrology, surgery, etc.

Clinical comparison of cTnI

Company profile

Zhongxiu Science And Technology Co.,Ltd., is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, microbial series, biochemical series and immune series reagents and supporting instruments.
The company has always adhered to the core concept of "fast and accurate, living up to life", committed to providing society with excellent products and services, and contributing to the cause of human health.

Zhongxiu Science And Technology Co.,Ltd., founded in 2016, is located in Dingluan Industrial Zone, Changyuan City, Henan Province. The company covers an area of about 100 acres and the initial investment is about 200 million yuan. The company has a scientific and complete management system, a purification workshop of national standards, and a fully functional inspection center. On this basis, the company will continue to invest in research and development, accumulate technical strength, update manufacturing equipment, improve production technology, improve inspection technology, improve product quality, and provide customers with safe and effective in vitro diagnostic products.

Zhongxiu Science And Technology Co., Ltd. is a high-tech enterprise engaged in the research and development, production and operation of in vitro diagnostic products. The in vitro diagnostic products developed by the company cover POCT series, immune series, microbial series and other reagents and supporting instruments.

The company has always adhered to the core concept of “fast and accurate, living up to life”, committed to providing society with excellent products and services, and contributing to the cause of human health.